l*6
1 楼
大家好，需要文章用于申请绿卡的材料。学校数据库好多都没有买。希望求助于大家。
请email到我的邮箱：l**********[email protected]。
以下是我所需的文章列表，谢谢。
(1) 高志玲, 孙丽媛, and 戴琎. "结核杆菌热休克蛋白 70 剂量相关的免疫调节作用.
" 中国免疫学杂志 29.7 (2013): 697-699.
(2) 刘波, 陈玲, and 张泓. "甲型流感病毒编码蛋白的突变及其致病机制." 病毒学报
4 (2013): 016.
(3) 李登云, 孙岩, 蒋鹏飞, 亢展展, 王静娜, 华琳琳, 张洋, and 张德礼. "H3N2 和
H1N1 甲型流感病毒感染对猪 CDK9 基因表达的影响." 西北农林科技大学学报: 自然
科学版 010 (2013): 14-18.
(4) 董磊, 刘娟, 马红雨, 全首祯, and 朱美财. "荧光素酶光学成像技术研究进展."
国际生物医学工程杂志 ISTIC 35, no. 6 (2012).
(5) 赖文彬, 汪世雄, and 叶昕. "Colletodiol 降低聚合酶活性抑制流感病毒 (WSN/
H1N1) 复制." 微生物学报 53, no. 012 (2013): 1334-1339.
(6) 向敏, 张克山, 卢顺, 蔡利军, 罗勇, 张建民, 何华, 王勤刚, and 吴斌. "Asia
I 口蹄疫 vp2 蛋白单克隆抗体的制备及单抗竞争 ELISA 方法的建立." 生物工程学报
24, no. 9 (2008): 1664-1669.
(7) Ruijuan, Du. "Brief description of baculovirus expression system
development." Letters in Biotechnology 4 (1999): 018.
(8) ZOU, Wei, Yu-jun ZHAO, Ling-yan MENG, Jian-jie YANG, and Yong LIU. "
Developments in new generation vaccine of Foot and Mouth Disease [J]."
Livestock and Poultry Industry 8 (2007): 003.
(9) Prokaryotic expression and antigenicity characterization of foot-and-
mouth disease virus VP2 gene. Chinese Journal of Preventive Veterinary
Medicine. 2007. QU Zhe-hui, WANG Jun-wei, GUO Xiao-qiu, LI Gang, LI Hong-tao
(10) ZHANG, Run-xiang, Ming-chun GAO, Zhe-hui QU, Shuang LI, Yong-sheng CAO,
Jun SONG, Ge SONG, Dan-dan LIU, and Jun-wei WANG. "Development of VP2
indirect ELISA for detection of cattle antibodies against foot-and-mouth
disease virus [J]." Chinese Journal of Preventive Veterinary Medicine 2 (
2010): 013.
(11) Na-na, Lu, Liu Qi, Gu Li-gang, Ge Shi-jie, Wu Jun, Qiu Ze-ji, Zhang
Hong-chun, Zhao En-xiang, Zhang Yi, and Yu Zhuo-nan. "Gene Expression
Profiles Underlying Selective T Cell-mediated Immunity Activity of a Chinese
Medicine Granule on Mice Infected with Influenza Virus H1N1."
(12) Moisy, Dorothée, and Nadia Naffakh. "Interactions moléculaires entre
les ribonucléoprotéines des virus influenza de type A et la cellule hô
;te." Virologie 17, no. 4 (2013): 278-293.
(13) Atkins, Colm, Carrie W. Evans, E. Lucile White, and James W. Noah. "
Screening methods for influenza antiviral drug discovery." Expert opinion on
drug discovery 7, no. 5 (2012): 429-438.
(14) Söderberg-Nauclér, Cecilia. "Treatment of cytomegalovirus
infections beyond acute disease to improve human health." Expert review of
anti-infective therapy 0 (2014): 1-12.
请email到我的邮箱：l**********[email protected]。
以下是我所需的文章列表，谢谢。
(1) 高志玲, 孙丽媛, and 戴琎. "结核杆菌热休克蛋白 70 剂量相关的免疫调节作用.
" 中国免疫学杂志 29.7 (2013): 697-699.
(2) 刘波, 陈玲, and 张泓. "甲型流感病毒编码蛋白的突变及其致病机制." 病毒学报
4 (2013): 016.
(3) 李登云, 孙岩, 蒋鹏飞, 亢展展, 王静娜, 华琳琳, 张洋, and 张德礼. "H3N2 和
H1N1 甲型流感病毒感染对猪 CDK9 基因表达的影响." 西北农林科技大学学报: 自然
科学版 010 (2013): 14-18.
(4) 董磊, 刘娟, 马红雨, 全首祯, and 朱美财. "荧光素酶光学成像技术研究进展."
国际生物医学工程杂志 ISTIC 35, no. 6 (2012).
(5) 赖文彬, 汪世雄, and 叶昕. "Colletodiol 降低聚合酶活性抑制流感病毒 (WSN/
H1N1) 复制." 微生物学报 53, no. 012 (2013): 1334-1339.
(6) 向敏, 张克山, 卢顺, 蔡利军, 罗勇, 张建民, 何华, 王勤刚, and 吴斌. "Asia
I 口蹄疫 vp2 蛋白单克隆抗体的制备及单抗竞争 ELISA 方法的建立." 生物工程学报
24, no. 9 (2008): 1664-1669.
(7) Ruijuan, Du. "Brief description of baculovirus expression system
development." Letters in Biotechnology 4 (1999): 018.
(8) ZOU, Wei, Yu-jun ZHAO, Ling-yan MENG, Jian-jie YANG, and Yong LIU. "
Developments in new generation vaccine of Foot and Mouth Disease [J]."
Livestock and Poultry Industry 8 (2007): 003.
(9) Prokaryotic expression and antigenicity characterization of foot-and-
mouth disease virus VP2 gene. Chinese Journal of Preventive Veterinary
Medicine. 2007. QU Zhe-hui, WANG Jun-wei, GUO Xiao-qiu, LI Gang, LI Hong-tao
(10) ZHANG, Run-xiang, Ming-chun GAO, Zhe-hui QU, Shuang LI, Yong-sheng CAO,
Jun SONG, Ge SONG, Dan-dan LIU, and Jun-wei WANG. "Development of VP2
indirect ELISA for detection of cattle antibodies against foot-and-mouth
disease virus [J]." Chinese Journal of Preventive Veterinary Medicine 2 (
2010): 013.
(11) Na-na, Lu, Liu Qi, Gu Li-gang, Ge Shi-jie, Wu Jun, Qiu Ze-ji, Zhang
Hong-chun, Zhao En-xiang, Zhang Yi, and Yu Zhuo-nan. "Gene Expression
Profiles Underlying Selective T Cell-mediated Immunity Activity of a Chinese
Medicine Granule on Mice Infected with Influenza Virus H1N1."
(12) Moisy, Dorothée, and Nadia Naffakh. "Interactions moléculaires entre
les ribonucléoprotéines des virus influenza de type A et la cellule hô
;te." Virologie 17, no. 4 (2013): 278-293.
(13) Atkins, Colm, Carrie W. Evans, E. Lucile White, and James W. Noah. "
Screening methods for influenza antiviral drug discovery." Expert opinion on
drug discovery 7, no. 5 (2012): 429-438.
(14) Söderberg-Nauclér, Cecilia. "Treatment of cytomegalovirus
infections beyond acute disease to improve human health." Expert review of
anti-infective therapy 0 (2014): 1-12.